Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecules (Basel, Switzerland)|July 14, 2023
Catalytic Decomposition of H<sub>2</sub>O<sub>2</sub> in the Aqueous Dispersions of the Potassium Polytitanates Produced in Different Conditions of Molten Salt SynthesisAlexander Gorokhovsky, Natalia Morozova, Gleb Yurkov, et al.
Genes|January 16, 2021
<i>RBM20</i>-Associated Ventricular Arrhythmias in a Patient with Structurally Normal HeartYuriy Vakhrushev, Alexandra Kozyreva, Andrey Semenov, et al.
The American Journal of Case Reports|December 19, 2015
Is Mixed Apnea Associated with Non-Rapid Eye Movement Sleep a Reversible Compensatory Sign of Heart Failure?Lyudmila Korostovtseva, Yulia Sazonova, Nadezhda Zvartau, et al.
Journal of Hematology & Oncology|November 14, 2021
Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignanciesIlya Tsimafeyeu, Maria Volkova, Galina Alekseeva, et al.
Frontiers in Genetics|March 11, 2022
Case Report: Two New Cases of Autosomal-Recessive Hypertrophic Cardiomyopathy Associated With <i>TRIM63</i>-Compound Heterozygous VariantSofiya Andreeva, Olga Chumakova, Elena Karelkina, et al.
Targeted Oncology|January 5, 2019
Phase 2 Multicenter Single-Arm Study of Second-Line Axitinib in Favorable Risk Patients with Metastatic Renal Cell Carcinoma: FavorAxIlya Tsimafeyeu, Pavel Borisov, Ahmed Abdelgafur, et al.
European Urology|December 21, 2024
Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based TherapyVadim S Koshkin, Pongwut Danchaivijitr, Woo Kyun Bae, et al.
BMC Cancer|July 25, 2024
A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302)Primo N Lara, Luis Villanueva, Carolina Ibanez, et al.
Cancer Medicine|December 26, 2025
Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMISMatthias Saar, Karim Fizazi, Neal D Shore, et al.
Lancet (London, England)|September 17, 2017
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trialDaniel P Petrylak, Ronald de Wit, Kim N Chi, et al.
Pageof 2